EMJ Podcast | Quickfire & Deep Dive
Why is the liver so unique in its regeneration properties, and what does this mean for organoid transplantation and liver disease? Learn more about regenerative hepatology in this series featuring Ludovic Vallier, an expert on the development of clinically relevant cell types from human pluripotent stem cells. Join Vallier and host Saranya Ravindran as they explore how these technologies can be used to change the liver disease landscape and alleviate the challenges associated with liver transplantation.
Speaker Bio:
Ludovic Vallier leads a pioneering group within the BIH Centre for Regenerative Therapies, Berlin, Germany, focusing on the development of clinically relevant liver cell types using human pluripotent stem cells. His work spans disease modelling, drug discovery, and cell-based therapies for liver disorders. Beyond academia, he is the founder of the biotechnology companies DefiniGEN, Cambridge, UK, and BiliTech, Hitchin, UK, which are dedicated to advancing stem cell-derived liver models and cell therapies.
